Skip to main content
TipRanks
Go Ultimate75% OFF

Michael J. Detke Insider Profile

4 Followers

Michael J. Detke, CMO at IRulya Therapeutics, holds 140.00K shares in IRulya Therapeutics (Ticker: IRLA).

Michael J. Detke's Trading History

IRLA
IRulya Therapeutics
Mar 04, 2022CMOUninformative Buy―$5.57M
IRLA
Insider Shares: 140.00K (0.00%)

Michael J. Detke has not reported any informative transactions for IRLA, therefore, performance cannot be measured.

DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 04, 2022Uninformative Buy$0.00140,000$0.00―
Aug 12, 2021Uninformative Sell$1.00M10,000$100.00―
Aug 12, 2021Uninformative Buy$22.30K10,000$2.23―
Jul 07, 2021Uninformative Sell$3.15M58,261$54.03―
Jul 07, 2021Uninformative Buy$66.90K30,000$2.23―

You May Also Like

Michael J. Detke insider profile FAQ

What stocks does Michael J. Detke hold?
Michael J. Detke holds: IRLA stocks.
What is Michael J. Detke's role in IRulya Therapeutics?
Michael J. Detke's role in IRulya Therapeutics is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.